Stock SABS SAB BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart SAB Biotherapeutics, Inc.

Equities

SABS

US78397T2024

Market Closed - Nasdaq
Other stock markets
 01:30:00 01/06/2024 am IST 		5-day change 1st Jan Change
2.64 USD -.--% Intraday chart for SAB Biotherapeutics, Inc. -2.94% -61.60%
30/05 SAB Biotherapeutics, Inc. Announces Change of Chief Financial Officer CI
21/05 FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
SAB BIOTHERAPEUTICS, INC. Stock SAB Biotherapeutics, Inc.
 2.44Cr - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 12TCr
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 11TCr
BIONTECH SE Stock BioNTech SE
 2.43TCr -
ARGENX SE Stock argenx SE
 2.2TCr -
GENMAB A/S Stock Genmab A/S
 1.82TCr
  1. Stock Market
  2. Equities
  3. SABS Stock
  4. Charts SAB Biotherapeutics, Inc.
  5. Sector Chart